NURS 6521 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

Sample Answer for NURS 6521 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders Included After Question

Gastrointestinal (GI) and hepatobiliary disorders affect the structure and function of the GI tract. Many of these disorders often have similar symptoms, such as abdominal pain, cramping, constipation, nausea, bloating, and fatigue. Since multiple disorders can be tied to the same symptoms, it is important for advanced practice nurses to carefully evaluate patients and prescribe a treatment that targets the cause rather than the symptom.

Once the underlying cause is identified, an appropriate drug therapy plan can be recommended based on medical history and individual patient factors. In this Assignment, you examine a case study of a patient who presents with symptoms of a possible GI/hepatobiliary disorder, and you design an appropriate drug therapy plan.

To Prepare

  • Review the case study assigned by your Instructor for this Assignment
  • Reflect on the patient’s symptoms, medical history, and drugs currently prescribed.
  • Think about a possible diagnosis for the patient. Consider whether the patient has a disorder related to the gastrointestinal and hepatobiliary system or whether the symptoms are the result of a disorder from another system or other factors, such as pregnancy, drugs, or a psychological disorder.
  • Consider an appropriate drug therapy plan based on the patient’s history, diagnosis, and drugs currently prescribed.

By Day 7 of Week 4

Write a 1-page paper that addresses the following:

  • Explain your diagnosis for the patient, including your rationale for the diagnosis.
  • Describe an appropriate drug therapy plan based on the patient’s history, diagnosis, and drugs currently prescribed.
  • Justify why you would recommend this drug therapy plan for this patient. Be specific and provide examples.

Reminder: The College of Nursing requires that all papers submitted include a title page, introduction, summary, and references. The Sample Paper provided at the Walden Writing Center offers an example of those required elements (available at http://writingcenter.waldenu.edu/57.htm). All papers submitted must use this formatting.

Submission and Grading Information

To submit your completed Assignment for review and grading, do the following:

  • Please save your Assignment using the naming convention “WK4Assgn+last name+first initial.(extension)” as the name.
  • Click the Week 4 Assignment Rubric to review the Grading Criteria for the Assignment.
  • Click the Week 4 Assignment link. You will also be able to “View Rubric” for grading criteria from this area.
  • Next, from the Attach File area, click on the Browse My Computer button. Find the document you saved as “WK4Assgn+last name+first initial.(extension)” and click Open.
  • If applicable: From the Plagiarism Tools area, click the checkbox for I agree to submit my paper(s) to the Global Reference Database.
  • Click on the Submit button to complete your submission.

A Sample Answer For the Assignment: NURS 6521 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

Title: NURS 6521 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

The scenario depicts patient HL presenting with nausea, vomiting, and diarrhea. HL has a history of drug abuse and possible Hepatitis C. The patient is currently on Synthroid 100 mcg, Nifedipine 30 mg, and Prednisone 10 mg. Therefore, this paper seeks to discuss the diagnosis and drug therapy for this patient. 

Diagnosis 

Hepatitis C Virus (HCV) infection is a likely diagnosis for this patient. Clinical manifestations include fatigue, fever, night sweats, chills, joint pain, muscle pain, pruritus, lymphadenopathy, and spider nevi (Moosavy et al., 2017). GI symptoms include appetite changes, nausea, abdominal pain, diarrhea, jaundice, and indigestion (Moosavy et al., 2017). Pertinent positive findings consistent with HCV infection include nausea, vomiting, and diarrhea. HCV infection can be attributed to the patient’s history of drug abuse and Hepatitis C (Hojati et al., 2018). However, the symptoms can be associated with the side effects of the medications. Nausea is a side effect of Nifedipine and Prednisone, while diarrhea is a side effect of Synthroid.

NURS 6521 Assignment Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders
NURS 6521 Assignment Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

Drug Therapy 

Drug therapy should eradicate HCV and prevent the progress of HCV infection to cirrhosis, hepatocellular carcinoma, or liver failure (Nardelli et al., 2017). The drug therapy for the HCV infection diagnosis is Sofosbuvir/Peginterferon/Ribavirin combination for 12 weeks (Chung et al., 2018). The combination has a high treatment response and is recommended for drug abusers because it decreases the risk of self-injection (Hojati et al., 2018). I would recommend the therapy since it has few side effects, which will promote compliance. In addition, I would reduce the dose of current medications, Nifedipine to 10 mg and Prednisone to 5 mg, to minimize the side effects. 

Conclusion 

The patient has a likely diagnosis of HCV infection based on symptoms of nausea, vomiting, and diarrhea and a history of drug abuse and Hepatitis C. Sofosbuvir/Peginterferon/Ribavirin combination for 12 weeks would be appropriate since it has a high response for drug abusers and has few side effects. 

References 

Chung, R. T., Ghany, M. G., Kim, A. Y., Marks, K. M., Naggie, S., Vargas, H. E., Aronsohn, A.I., Bhattacharya, D., Broder, T., Falade-Nwulia, O.O.,& Fontana, R. J. (2018). Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection. Clinical Infectious Diseases. 

Hojati, S. A., Maserat, E., Ghorbani, M., Safarpour, A., & Fattehi, M. R. (2018). Hepatitis C Treatment in Patients with Drug Addiction Is Effective or Not Effective? Medical archives (Sarajevo, Bosnia and Herzegovina), 72(5), 325–329. doi:10.5455/medarh.2018.72.325-329 

Moosavy, S. H., Davoodian, P., Nazarnezhad, M. A., Nejatizaheh, A., Eftekhar, E., & Mahboobi, H. (2017). Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection. Electronic physician, 9(10), 5646–5656. https://doi.org/10.19082/5646 

Nardelli, S., Riggio, O., Rosati, D., Gioia, S., Farcomeni, A., &Ridola, L. (2019). Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms. World Journal of Gastroenterology, 25(48), 6928. 

A Sample Answer 2 For the Assignment: NURS 6521 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

Title: NURS 6521 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

Hepatitis C is one of the main sources of cirrhosis and builds the danger of wellbeing difficulties, particularly when there is liver irritation. Before interceding, there is a need to comprehend the patient’s clinical history since it may impact measures to improve the patient’s prosperity (Rosenthal & Burchum, 2020). For example, prednisone smothers the immune system, and there is a need to comprehend why the patient is utilizing the intercession. The clinical history likewise extends to the period when the side effects have happened and Hepatitis.

Primary Diagnosis

Although a comprehensive history and physical assessment, a diagnostic workup is expected to concoct a primary diagnostic; in light of the introducing symptoms, I will give a primary finding of intense gastroenteritis (Chalasani, Younossi, & Lavine, 2018). The cause is that the stomach and intestinal system are frequently triggered by the virus and bacterial disturbances/aggravation of foods sullied with viruses and parasites. Squeezing, nausea, groaning, or running can have symptoms. Most of the disease efficiently spread from contact with a weakened person or consumes, and drinks of sullied food or foods often spread the disease (Arcangel & Peterson, 2017). The signs typically occur one to three days after pollution. Because the patient is sick, loose, and thick bowels and does not have a fever, I would end up with severe bacterial gastroenteritis. NURS 6521 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

Differential Diagnosis

In the context of the history of the patient’s drug abuse, I will be speaking of a specific assessment of hepatitis C severity in the use of IV medicines and of adding indications. Hepatitis C is a serious hepatitis disease caused by hepatitis C infection. It usually results from harming blood or bodily fluid, sex, or needle exchange, which may be severe unclear stomach torment, and often diarrhea, individually or separately. It may be caused by the use of illicit drugs or drugs (Rosenthal & Burchum, 2020). Intense hepatitis C causes diarrhea. Though this underlying infection is most unlikely to cause signs, about 21-30 % of people show indicators approximately 1 to 3 months after the infection has occurred.

Drug Therapy and Treatment Plan

The primary goal of treatment is lessening the indications and the avoidance of complications. Because the patient is vomiting, dehydration and diarrhea, either 0.8 percent of intravenous liquid hydration will lead to the depletion of fluid from and runs and will avoid further dehydration (Chalasani, Younossi, & Lavine, 2018). I advise the patient to drink clear beverages and stock to support the lack of supplants and electrolytes as nausea subsides. On the other hand, if it is bacterial contamination, I will proceed with IV liquid and an anti-infection like an expansive range anti-toxin like Ciprofloxacin.

References

Arcangel, V. P., & Peterson, A. M. (2017). Pharmacotherapeutics for Advanced Practice: A Practical Approach. Wolters Kluwer.

Chalasani, N., Younossi, Z., & Lavine, J. E. (2018). The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology, 328-357.

Rosenthal, L., & Burchum, J. (2020). Lehne’s Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants. Elsevier – Health Sciences Division.

A Sample Answer 3 For the Assignment: NURS 6521 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

Title: NURS 6521 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

Today I am going to discuss the presented case scenario.  In the scenario there is a 27-year-old male found down and unresponsive for

unknown amount of time by his roommate.  The male was given naloxone by EMS and became responsive complaining of burning pain to his left greater trochanter and left forearm.  In the ED he was found to have a large amount of necrotic tissue over the greater trochanter and forearm.  His EKG was abnormal with a prolonged PR interval and elevated T waves.  His potassium level was at 6.9 which was elevated.

Click here to ORDER NOW FOR AN ORIGINAL PAPER ON NURS 6521 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

The Role Genetics Plays in the Disease

According to the National Institute on Drug Abuse (2019), 99.9 percent of any two people have the same DNA sequences.  The 0.1 percent difference is very important because it accounts for three million differences in almost three billion base pairs of DNA sequences (National Institute on Drug Abuse, 2019).  These differences are what contributes to certain diseases such as addiction (National Institute on Drug Abuse, 2019).  According to the American Psychological Association (2008), genetics can play a role in addiction and at least half of a persons’ susceptibility to drug addiction can be linked to genetic factors.

Why the Patient is Presenting with the Specific Symptoms Described

The patient overdosed on an opioid drug.  According to Schiller et. al. (2020), when an opiate is used in large amounts the opiate pathway is stimulated.  The over stimulation decreases the respiratory status of the patient (Schiller et al., 2020).  Once the patient’s respiratory status decreased, he became unresponsive and laid on the floor on his left side for a period of time as evidenced by his left greater trochanter and left forearm suffering from necrosis.  According to Simon et al. (2020), the blood flow was decreased, which causes a decrease in circulation, which causes a shift in potassium levels, and this causes cardiac irregularities.

The Physiologic Response to the Stimulus and Why the Response Occurred

According to Schiller et al. (2020), overdose of an opioid occurs when the patient over stimulates their opiate pathway.  When the over stimulation occurs the respiratory status decreases (Schiller et al., 2020).  When the opioid enters the body it goes to the synapses, then to the heart and then to the lungs (Schiller et al., 2020).  In the lungs is where the blood is filled with oxygen before going back to the heart again (Schiller et al., 2020).  The heart then pumps the blood to the entire body and attaches opioid receptors (Schiller et al., 2020).  The heart then slows down and the opioid suppresses the neurological signal which causes oxygen levels to fall (Schiller et al., 2020).  The patient then became unresponsive and laid for an unknown period of time on his left side on the floor where he was found.  According to Schiller et al., (2020), the opiates act on opiate receptors in the brain which causes the mu receptor to release dopamine that blocks the signal of pain and decreases the level of consciousness.  With the patient unresponsive laying in the same position on his left side without any signal of pain necrosis set in to the tissue on the left greater trochanter and left forearm.  According to McCance & Huether (2019), when a cell dies it triggers an inflammatory response and plasma and protein is leaked out of the cells.  This process recruits’ leukocytes in host defense and tissue repair (McCance & Huether, 2019).  The patient’s blood supply was decreased to the greater trochanter and left forearm from the pressure of laying on them too long without movement. This caused the nucleus of the cells to swell.  Then the plasma membrane ruptured and caused cellular and nuclear lysis and inflammation to the areas discussed.  The living tissue broke down, releasing chemicals into the bloodstream and tissue damage occurred and became necrotic when the cells died.

Next the Naloxone was administered by the EMS.  According to the National Institute on Drug Abuse (2018), Naloxone is an opioid antagonist and it binds to the opioid receptors.  It reverses the effects of opioids and blocks them (National Institute on Drug Abuse, 2018).  Normal respirations then occur in the patient and they become responsive. They then start to feel pain again as well.  Once at the ED the patient was found to have an elevated serum potassium level and an EKG with a prolonged PR interval and elevated T waves.  According to Simon et al., (2020), dehydration leads to hypotension and decreased tissue perfusion.  Metabolic acidosis occurs next with decreased circulation of blood flow (Simon et al., 2020).  Next a shift in the potassium occurs, an intracellular shift, and this causes an elevated potassium level (Simon et al., 2020).  According to Yates & Manini (2012), an elevated potassium level causes a prolonged PR interval because opioids decrease sympathomimetic tone and rhythm disturbances occur due to a blockade of potassium.  With the peaked T waves an ion disturbance takes place because the potassium channels are being blocked (Yates & Manini, 2012).

The Cells That Are Involved in This Process

In this scenario the blood cells are involved because of the decrease in blood circulation.  The skeletal muscle cells are involved because the patient was down for a long period of time in the same position.  The nerve cells are involved because the feeling of pain was decreased because the pain receptors were blocked.  The skin cells are involved because of the necrosis that occurred.  So many cells were involved in this overdose and the repercussions from the overdose.

How Another Characteristic Would Change My Response

I am not sure any characteristic would change my response.  Characteristics such as gender, genetics, physical appearance or age would not affect my response.  Whether male or female, old or young, tall or short, with an opioid overdose as in this scenario used, the results would be the same.  If the scenario spoke of healing time, then my response would be different for an example.  The scenario given to me, is going to be the same outcome no matter the characteristics.  All bodies will respond the same way as in the scenario.

References

American Psychological Association. (2008). Genes matter in addiction. https://www.apa.org/monitor/2008/06/genes-addict

McCance, K.L., & Huether, S.E. (2019). Pathophysiology: The biologic basis for disease in adults and children (8thed.). St. Louis, MO: Mosby/Elsevier

National Institute on Drug Abuse. (2018). Opioid overdose reversal with Naloxone (Narcan, Evzio). https://www.drugabuse.gov/drug-topics/opioids/opioid-overdose-reversal-naloxone-narcan-evzio

National Institute on Drug Abuse. (2019). Genetics and epigenetics of addiction drug facts. https://www.drugabuse.gov/publications/drugfacts/genetics-epigenetics-addiction

Schiller, E. Y., Goyal, A., Cao, F., & Mechanic, O.J. (2020). Opioid overdose. In StatPearls. Treasure Island, FL: StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470415/

Simon, L.V., Hashmi, M.F., & Farrell, M.W. (2020). Hyperkalemia. In StatPearls. Treasure Island, FL: StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470284/

Yates, C., & Manini, A. (2012).Utility of the electrocardiogram in drug overdose and poisoning: Theoretical considerations and clinical implications. https://www/ncbi.nlm.nih.gov/pmc/articles/PMC3406273/

A Sample Answer 4 For the Assignment: NURS 6521 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

Title: NURS 6521 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

The case concerns HL, with nausea, vomiting, and diarrhea. The patient has a history of illicit drug use and a possible Hepatitis C infection. The current drug therapy includes Synthroid 100 mcg, Nifedipine 30 mg, and Prednisone 10 mg. The purpose of this paper is to discuss the diagnosis and drug therapy for this patient.

Diagnosis

The patient’s symptoms and medical history are consistent with Hepatitis C, which is caused by Hepatitis C virus (HCV). HCV is transmitted parenterally through contaminated blood from sharing and recycling syringes among drug users, unsafe sexual practices, and unsafe health practices like transfusing unscreened blood (Lazarus et al., 2020). The clinical manifestations of Hepatitis C include nausea, vomiting, anorexia, non-specific upper abdominal discomfort, jaundice, and malaise (Kouroumalis & Voumvouraki, 2022). However, some patients are asymptomatic. Hepatitis C is the presumptive diagnosis owing to the patient’s positive GI symptoms of nausea, vomiting, and diarrhea. In addition, the patient has a history of illicit drug use, which puts him at risk of contracting HCV and a history of Hepatitis C infection.

Drug Therapy Plan

Treatment guidelines for Hepatitis C recommend treatment with antiviral drugs following the initial diagnosis of the condition. Effective direct-acting antiviral drugs (DAAs) are recommended for hepatitis C to lower the chances of progressing to chronic infection. The patient’s treatment plan will include Ledipasvir/sofosbuvir (Harvoni) 1 tablet (90 mg/400 mg) orally once daily for 8 weeks (Chung et al., 2018). The oral combination of Ledipasvir and Sofosbuvir is used to treat adults with chronic hepatitis C, with or without cirrhosis.

Conclusion

Hepatitis C is the presumptive diagnosis for this patient based on the presence of GI symptoms like nausea, vomiting, and diarrhea. The patient may have contracted HCV from sharing syringes, or it could be a chronic infection considering the history of possible Hepatitis C. Treatment will be a combination of Ledipasvir and Sofosbuvir, which is recommended for chronic Hepatitis C.

References

Chung, R. T., Ghany, M. G., Kim, A. Y., Marks, K. M., Naggie, S., Vargas, H. E.,Aronsohn, A.I., Bhattacharya, D., Broder, T., Falade-Nwulia, O.O.,& Fontana, R. J. (2018). Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection. Clinical Infectious Diseases. DOI: 10.1093/cid/ciy585

Kouroumalis, E., & Voumvouraki, A. (2022). Hepatitis C virus: A critical approach to who really needs treatment. World journal of hepatology14(1), 1–44. https://doi.org/10.4254/wjh.v14.i1.1

Lazarus, J. V., Roel, E., & Elsharkawy, A. M. (2020). Hepatitis C Virus Epidemiology and the Impact of Interferon-Free Hepatitis C Virus Therapy. Cold Spring Harbor perspectives in medicine10(3), a036913. https://doi.org/10.1101/cshperspect.a036913

A Sample Answer 5 For the Assignment: NURS 6521 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

Title: NURS 6521 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

The case study depicts a 46-year-old female patient with a chief complaint of RUQ pain for the last 24 hours. The RUQ pain began an hour after dinner, and she had nausea and vomiting x1 before the pain started. The abdomen is non-distended but has mild tenderness. Lab results revealed a high WBC count and Direct bilirubin. The purpose of this paper is to discuss the patient’s diagnosis and treatment plan.

Diagnosis

Hepatitis A is the identified diagnosis for this case. It is caused by the hepatitis A virus (HAV) transmitted via the fecal-oral route through person-to-person contact and ingesting contaminated food or water. The classical presentation in adults includes anorexia, RUQ pain, jaundice, and hyperbilirubinemia (Abutaleb & Kottilil, 2020). Hepatitis A is the presumptive diagnosis based on pertinent positive symptoms of nausea, vomiting, RUQ pain, abdominal tenderness, and high direct bilirubin levels. Besides, an elevated WBC count indicates an underlying infection.

Drug Therapy Plan

Treatment of Hepatitis A is usually supportive. I would recommend Acetaminophen 500 mg per oral twice daily to relieve pain. Pain relief is important to promote quality patient care in the acute phase of Hepatitis A (Ntouva et al., 2019). In addition, I would recommend Metoclopramide 10 mg PRN. Metoclopramide is an antiemetic and will be important to alleviate nausea and vomiting. In addition, inactivated Hepatitis A vaccine will be administered for active immunization against diseases associated with HAV (Ntouva et al., 2019).

Conclusion

The patient presented with symptoms consistent with Hepatitis A, such as nausea, RUQ pain, mild abdominal tenderness, hyperbilirubinemia, and an elevated WBC count. Hepatitis A could be due to transmission of HAV from contaminated food or water. The treatment plan will include supportive measures such as pain control and alleviating nausea and vomiting using an analgesic and antiemetic.

References

Abutaleb, A., & Kottilil, S. (2020). Hepatitis A: Epidemiology, Natural History, Unusual Clinical Manifestations, and Prevention. Gastroenterology clinics of North America49(2), 191–199. https://doi.org/10.1016/j.gtc.2020.01.002

Ntouva, A., Sibal, B., Balogun, K., Mandal, S., & Harding, N. (2019). Hepatitis A in primary care: working in partnership for diagnosis, management, and prevention of outbreaks. The British journal of general practice : the journal of the Royal College of General Practitioners69(687), 521–522. https://doi.org/10.3399/bjgp19X705965